Group One Trading
FBIO icon

Group One Trading’s Fortress Biotech FBIO Stock Holding History

Group One Trading’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.1K Sell
9,700
-9,000
-48% -$30.6K ﹤0.01% 5753
2025
Q4 		$68.4K Sell
18,700
-9,200
-33% -$26.2K ﹤0.01% 5325
2025
Q3 		$103K Buy
27,900
+5,900
+27% +$14.9K ﹤0.01% 5319
2025
Q2 		$40.9K Sell
22,000
-79,900
-78% -$138K ﹤0.01% 5736
2025
Q1 		$159K Buy
101,900
+66,900
+191% +$118K ﹤0.01% 4208
2024
Q4 		$70.9K Buy
35,000
+4,000
+13% +$7.25K ﹤0.01% 4802
2024
Q3 		$44.8K Buy
31,000
+19,600
+172% +$37.3K ﹤0.01% 4732
2024
Q2 		$19.5K Buy
11,400
+10,000
+714% +$18.1K ﹤0.01% 5251
2024
Q1 		$2.8K Buy
+1,400
New +$2.79K ﹤0.01% 6404
2022
Q1 		– Sell
-1,333
Closed -$50K – 8215
2021
Q4 		$50K Buy
1,333
+666
+100% +$29.7K ﹤0.01% 6342
2021
Q3 		$32K Sell
667
-493
-43% -$24.1K ﹤0.01% 6869
2021
Q2 		$62K Buy
+1,160
New +$70K ﹤0.01% 6390
2018
Q4 		– Sell
-333
Closed -$8K – 5009
2018
Q3 		$8K Hold
333
– – ﹤0.01% 4714
2018
Q2 		$15K Buy
+333
New +$18.7K ﹤0.01% 4482
2016
Q4 		– Sell
-5,320
Closed -$237K – 4523
2016
Q3 		$237K Buy
+5,320
New +$226K ﹤0.01% 2343
2015
Q3 		– Sell
-13
Closed -$1K – 4938
2015
Q2 		$1K Sell
13
-7
-35% -$359 ﹤0.01% 4743
2015
Q1 		$1K Buy
+20
New +$834 ﹤0.01% 4638
2014
Q4 		– Sell
-12,880
Closed -$406K – 5010
2014
Q3 		$406K Sell
12,880
-1,200
-9% -$31.9K 0.01% 1776
2014
Q2 		$363K Buy
14,080
+11,387
+423% +$300K 0.01% 1909
2014
Q1 		$80K Sell
2,693
-2,040
-43% -$79.6K ﹤0.01% 3255
2013
Q4 		$187K Buy
4,733
+1,640
+53% +$63.3K ﹤0.01% 2495
2013
Q3 		$326K Buy
3,093
+1,700
+122% +$208K 0.01% 1969
2013
Q2 		$180K Buy
+1,393
New +$205K ﹤0.01% 2274

Other funds holding FBIO

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Group One Trading's FBIO Position: Q1 2026 in Review

Group One Trading sold out of Fortress Biotech (FBIO) in Q1 2026, closing a stake of 63,692 shares — an estimated $216K sold.

Group One Trading first reported a position in FBIO in Q2 2013 and held it in 25 quarters. The position peaked at $311K in Q2 2013. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • Group One Trading reported no remaining Fortress Biotech position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 63,692 Fortress Biotech shares in Q1 2026, an estimated $216K.
  • Group One Trading first reported a position in Fortress Biotech in Q2 2013 and held it in 25 quarters.
  • Group One Trading's Fortress Biotech position peaked at $311K in Q2 2013.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.